borderline significantP = 0.050
Impact of COVID-19 Our statistical analysis revealed that individuals with a history of COVID-19 infection had a higher risk of developing IBS compared to those without such a history, although this result was only borderline significant (OR = 1.47, 95% CI 1.01–2.15, P = 0.050).